| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
BCLI
Brainstorm Cell Therapeutics
|
Aug 18, 2026 | HOLD |
Hold
+228.5% avg upside
2 analysts
|
— | · | · |
|
AKTX
Akari Therapeutics
|
Aug 18, 2026 | BUY |
Strong Buy
+1114.2% avg upside
7 analysts
|
$30.00
272.18% Upside
|
· | · |
|
ANVS
Annovis Bio
|
Aug 17, 2026 | BUY |
Strong Buy
+1108.6% avg upside
8 analysts
|
$8.00
334.85% Upside
|
· | · |
|
CODX
Co-Diagnostics
|
Aug 17, 2026 | BUY |
Buy
+1659.4% avg upside
5 analysts
|
$4.00
210.18% Upside
|
· | · |
|
RNTX
Rein Therapeutics
|
Aug 17, 2026 | BUY |
Strong Buy
+1036.8% avg upside
6 analysts
|
$4.00
406.65% Upside
|
· | · |
|
MBRX
Moleculin Biotech
|
Aug 17, 2026 | BUY |
Strong Buy
+3064.8% avg upside
5 analysts
|
$2.00
244.83% Upside
|
· | · |
|
MTVA
MetaVia
|
Aug 17, 2026 | BUY |
Strong Buy
+1928.5% avg upside
13 analysts
|
$8.00
440.48% Upside
|
+0.3% | · |
|
UNCY
Unicycive Therapeutics
|
Aug 17, 2026 | BUY |
Strong Buy
+831.1% avg upside
10 analysts
|
$30.00
433.80% Upside
|
-2.1% | · |
|
DARE
Daré Bioscience
|
Aug 14, 2026 | BUY |
Strong Buy
+1526.8% avg upside
14 analysts
|
$8.00
863.76% Upside
|
-17.4% | · |
|
GNLX
Genelux Corp.
|
Aug 14, 2026 | BUY |
Strong Buy
+577.7% avg upside
7 analysts
|
$12.00
352.74% Upside
|
+0.0% | · |
|
FEMY
Femasys
|
Aug 14, 2026 | BUY |
Strong Buy
+2262.5% avg upside
6 analysts
|
$10.00
278.75% Upside
|
-3.9% | · |
|
DWTX
Dogwood Therapeutics
|
Aug 14, 2026 | BUY |
Strong Buy
+478.9% avg upside
2 analysts
|
$15.00
538.25% Upside
|
+0.0% | · |
|
APRE
Aprea Therapeutics
|
Aug 14, 2026 | BUY |
Buy
+3308.7% avg upside
7 analysts
|
$5.00
646.08% Upside
|
+0.0% | · |
|
PMN
ProMIS Neurosciences
|
Aug 14, 2026 | BUY |
Strong Buy
+342.3% avg upside
9 analysts
|
$35.00
139.98% Upside
|
+0.0% | · |
|
CAPR
Capricor Therapeutics
|
Aug 14, 2026 | HOLD |
Buy
+116.2% avg upside
12 analysts
|
— | +0.0% | · |
|
MNOV
Medicinova
|
Aug 14, 2026 | BUY |
Strong Buy
+441.3% avg upside
5 analysts
|
$6.00
336.38% Upside
|
+0.0% | · |
|
FENC
Fennec Pharmaceuticals
|
Aug 13, 2026 | BUY |
Strong Buy
+43.1% avg upside
9 analysts
|
$20.00
69.54% Upside
|
-6.4% | · |
|
NTHI
NeOnc Technologies Holdings, Inc.
|
Aug 13, 2026 | BUY |
Strong Buy
+222.1% avg upside
3 analysts
|
$20.00
314.97% Upside
|
+31.5% | · |
|
MDCX
Medicus Pharma Ltd
|
Aug 13, 2026 | BUY |
Strong Buy
+4359.2% avg upside
5 analysts
|
$2.00
683.62% Upside
|
-20.9% | · |
|
GANX
Gain Therapeutics
|
Aug 13, 2026 | BUY |
Strong Buy
+282.9% avg upside
9 analysts
|
$7.00
242.59% Upside
|
-8.6% | · |
|
IKT
Inhibikase Therapeutics
|
Aug 13, 2026 | BUY |
Strong Buy
+145.2% avg upside
8 analysts
|
$8.00
227.77% Upside
|
+0.0% | · |
|
CLRB
Cellectar Biosciences
|
Aug 13, 2026 | BUY |
Buy
+2710.9% avg upside
8 analysts
|
$10.00
276.72% Upside
|
+4.8% | · |
|
AIM
AIM ImmunoTech
|
Aug 12, 2026 | BUY |
Buy
+1852.9% avg upside
5 analysts
|
$1.50
506.54% Upside
|
-15.4% | · |
|
SCYX
SCYNEXIS
|
Aug 12, 2026 | BUY |
Strong Buy
+147.0% avg upside
10 analysts
|
$32.00
504.98% Upside
|
+7.7% | · |
|
ACHV
Achieve Life Sciences
|
Aug 12, 2026 | BUY |
Strong Buy
+84.2% avg upside
15 analysts
|
$10.00
17.49% Upside
|
+10.3% | · |
|
SLS
SELLAS Life Sciences Group
|
Aug 12, 2026 | BUY |
Strong Buy
+401.1% avg upside
16 analysts
|
$30.00
118.33% Upside
|
+8.6% | · |
|
TOVX
Theriva Biologics
|
Aug 11, 2026 | BUY |
Strong Buy
+3456.4% avg upside
8 analysts
|
$1.00
329.81% Upside
|
+0.0% | · |
|
INMB
Inmune Bio
|
Aug 11, 2026 | BUY |
Buy
+457.6% avg upside
11 analysts
|
$8.00
255.54% Upside
|
+4.3% | · |
|
BNGO
BioNano Genomics
|
Aug 11, 2026 | BUY |
Buy
+678.3% avg upside
9 analysts
|
$4.00
225.22% Upside
|
+2.5% | · |
|
ATOS
Atossa Therapeutics
|
Aug 11, 2026 | BUY |
Strong Buy
+505.8% avg upside
7 analysts
|
$10.00
270.40% Upside
|
+10.6% | · |
|
IMNN
Imunon
|
Aug 11, 2026 | BUY |
Strong Buy
+824.3% avg upside
11 analysts
|
$10.00
517.18% Upside
|
+2.5% | · |
|
CNTX
Context Therapeutics
|
Aug 10, 2026 | BUY |
Strong Buy
+983.6% avg upside
12 analysts
|
$4.00
760.86% Upside
|
+15.7% | · |
|
TLSI
TriSalus Life Sciences
|
Aug 10, 2026 | BUY |
Strong Buy
+77.3% avg upside
8 analysts
|
$14.00
152.64% Upside
|
-5.6% | · |
|
ZVRA
Zevra Therapeutics
|
Aug 06, 2026 | BUY |
Strong Buy
+81.0% avg upside
15 analysts
|
$35.00
192.46% Upside
|
-4.7% | · |
|
CHRS
Coherus Biosciences
|
Aug 06, 2026 | BUY |
Buy
+835.0% avg upside
18 analysts
|
$4.00
201.79% Upside
|
+5.1% | · |
|
FLNA
Filana Therapeutics
|
Jul 29, 2026 | BUY |
Buy
+4193.0% avg upside
4 analysts
|
$5.00
415.54% Upside
|
+4.6% | · |
|
ES:ORY
Oryzon Genomics SA
|
Jul 28, 2026 | BUY |
Strong Buy
+265.1% avg upside
2 analysts
|
$8.64
205.66% Upside
|
+0.1% | · |
|
KAPA
Kairos Pharma, Ltd.
|
Jul 23, 2026 | BUY |
Strong Buy
+3432.9% avg upside
4 analysts
|
— | +14.4% | · |
|
BLFS
BioLife Solutions
|
Jul 23, 2026 | HOLD |
Buy
-18.2% avg upside
17 analysts
|
— | +18.5% | · |
|
IMMP
Immutep
|
Jun 17, 2026 | BUY |
Strong Buy
+1271.1% avg upside
7 analysts
|
$1.50
281.63% Upside
|
+2.7% | · |
|
ATHE
Alterity Therapeutics
|
Jun 10, 2026 | BUY |
Strong Buy
+112.8% avg upside
7 analysts
|
$12.00
163.64% Upside
|
+9.9% | · |
|
RZLT
Rezolute
|
Jun 03, 2026 | BUY |
Strong Buy
+126.4% avg upside
13 analysts
|
$14.00
197.80% Upside
|
+0.4% | · |
|
ONCY
Oncolytics Biotech
|
May 21, 2026 | BUY |
Strong Buy
+709.8% avg upside
12 analysts
|
$3.00
260.15% Upside
|
+1.3% | · |
|
CNSY
Cerenome
|
May 19, 2026 | BUY |
Strong Buy
+909.5% avg upside
11 analysts
|
$12.00
290.93% Upside
|
-47.2% | · |
|
OSTX
OS Therapies Incorporated
|
May 19, 2026 | BUY |
Strong Buy
+667.7% avg upside
5 analysts
|
$6.00
313.81% Upside
|
-18.2% | · |
|
HIND
Vyome Holdings
|
May 19, 2026 | BUY |
Strong Buy
+1268.6% avg upside
8 analysts
|
$15.00
541.01% Upside
|
+8.5% | · |
|
CNSP
CNS Pharmaceuticals
|
May 15, 2026 | BUY |
Strong Buy
+366.4% avg upside
5 analysts
|
$10.00
68.09% Upside
|
+11.5% | · |
|
AZTR
Azitra Inc
|
May 14, 2026 | BUY |
Strong Buy
+699.5% avg upside
1 analyst
|
$1.00
699.45% Upside
|
-32.3% | · |
|
ACXP
Acurx Pharmaceuticals
|
May 12, 2026 | BUY |
Strong Buy
+4955.8% avg upside
4 analysts
|
$10.00
614.22% Upside
|
-31.9% | · |
|
ADIL
Adial Pharmaceuticals
|
May 12, 2026 | BUY |
Strong Buy
+686.8% avg upside
7 analysts
|
$8.00
43.35% Upside
|
+188.4% | · |
|
ANIX
Anixa Biosciences
|
May 11, 2026 | BUY |
Strong Buy
+174.3% avg upside
4 analysts
|
$14.00
269.44% Upside
|
+5.0% | · |
|
PLYX
Polaryx Therapeutics, Inc.
|
Apr 21, 2026 | BUY |
Strong Buy
+260.5% avg upside
3 analysts
|
$10.00
379.68% Upside
|
-50.7% | · |
|
MESO
Mesoblast
|
Apr 14, 2026 | BUY |
Strong Buy
+44.6% avg upside
14 analysts
|
$35.00
106.49% Upside
|
+6.8% | · |
|
RVPH
Reviva Pharmaceuticals Holdings
|
Apr 08, 2026 | HOLD |
Strong Buy
+8985.5% avg upside
9 analysts
|
— | -35.4% | · |
|
ATNM
Actinium Pharmaceuticals
|
Apr 07, 2026 | BUY |
Strong Buy
+513.2% avg upside
11 analysts
|
$5.00
346.52% Upside
|
-11.1% | · |
|
ITRMF
Iterum Therapeutics
|
Mar 05, 2026 | HOLD |
Hold
+71666566.7% avg upside
5 analysts
|
— | · | · |
|
HURA
TuHURA Biosciences
|
Mar 03, 2026 | BUY |
Strong Buy
+304.2% avg upside
8 analysts
|
$8.00
255.55% Upside
|
+59.4% | · |
|
IVF
INVO Fertility
|
Feb 10, 2026 | BUY |
Strong Buy
+721.9% avg upside
3 analysts
|
$20.00
1701.80% Upside
|
-82.5% | · |
|
QNCX
Quince Therapeutics
|
Feb 02, 2026 | HOLD |
Buy
+549.4% avg upside
16 analysts
|
— | · | · |
|
GNTA
Genenta Science SpA Sponsored ADR
|
Dec 22, 2025 | BUY |
Strong Buy
+1185.8% avg upside
3 analysts
|
$7.00
478.61% Upside
|
-11.6% | · |
|
VTGN
VistaGen Therapeutics
|
Dec 17, 2025 | HOLD |
Hold
+964.8% avg upside
8 analysts
|
— | -68.6% | · |
|
ARTL
Artelo Biosciences
|
Nov 19, 2025 | HOLD |
Hold
2 analysts
|
— | -85.8% | · |
|
RNXT
RenovoRx
|
Nov 14, 2025 | BUY |
Strong Buy
+390.4% avg upside
5 analysts
|
$4.00
207.65% Upside
|
+75.3% | · |
|
INDP
Indaptus Therapeutics
|
Nov 13, 2025 | BUY |
Buy
+9764.2% avg upside
6 analysts
|
$10.00
952.72% Upside
|
-63.8% | · |
|
CERO
CERo Therapeutics Holdings
|
Nov 07, 2025 | HOLD |
Hold
+614.3% avg upside
2 analysts
|
$0.10
614.26% Upside
|
-90.8% | · |
|
NEUP
Neuphoria Therapeutics
|
Oct 30, 2025 | BUY |
Strong Buy
+406.0% avg upside
6 analysts
|
$20.00
408.96% Upside
|
-12.0% | · |
|
ABPO
Abpro Holdings
|
Oct 21, 2025 | HOLD |
Hold
1 analyst
|
— | · | · |
|
CMMB
Chemomab Therapeutics
|
May 06, 2025 | BUY |
Strong Buy
+1260.0% avg upside
6 analysts
|
$28.00
1335.88% Upside
|
-63.3% | · |
|
BNBX
BNB Plus
|
Feb 27, 2025 | HOLD |
Buy
+6711.6% avg upside
5 analysts
|
— | · | · |
|
KZIA
Kazia Therapeutics
|
Feb 24, 2025 | BUY |
Strong Buy
+80.7% avg upside
8 analysts
|
$15.00
4.77% Upside
|
+50.3% | · |
|
LIPO
Lipella Pharmaceuticals, Inc.
|
Feb 11, 2025 | BUY |
Strong Buy
+2499900.0% avg upside
1 analyst
|
$10.00
2499899.95% Upside
|
· | · |
|
BRTX
BioRestorative Therapies
|
Feb 11, 2025 | BUY |
Strong Buy
+3583.6% avg upside
3 analysts
|
$8.00
3473.06% Upside
|
-82.1% | · |
|
ATXI
Avenue Therapeutics
|
Nov 15, 2024 | BUY |
Strong Buy
+6887.6% avg upside
4 analysts
|
— | -60.6% | · |
|
MTNB
Matinas BioPharma
|
Oct 31, 2024 | HOLD |
Buy
+6946.6% avg upside
7 analysts
|
— | +122.6% | · |
|
TAOX
Tao Synergies
|
Jul 11, 2024 | BUY |
Strong Buy
+302.3% avg upside
1 analyst
|
$14.00
302.30% Upside
|
+106.2% | · |
|
BLTE
Belite Bio, Inc. ADR
|
Mar 13, 2024 | BUY |
Strong Buy
+10.8% avg upside
10 analysts
|
$60.00
64.25% Downside
|
+82.8% | · |
|
DFTX
Definium Therapeutics
|
Mar 11, 2024 | BUY |
Strong Buy
+13.7% avg upside
22 analysts
|
— | -24.0% | · |
|
LCTX
Lineage Therap
|
Mar 11, 2024 | BUY |
Strong Buy
+404.9% avg upside
16 analysts
|
$5.00
352.48% Upside
|
-58.9% | · |
|
CMPS
COMPASS Pathways
|
Mar 04, 2024 | BUY |
Strong Buy
+59.0% avg upside
20 analysts
|
$22.00
57.31% Upside
|
-66.5% | · |
|
VNRX
VolitionRX
|
Oct 27, 2023 | BUY |
Strong Buy
+1923.7% avg upside
11 analysts
|
$4.00
731.34% Upside
|
-13.6% | · |
|
BIOCQ
Biocept
|
Sep 21, 2023 | HOLD |
Strong Buy
+84074899.9% avg upside
7 analysts
|
— | · | · |
|
CFRXQ
ContraFect
|
Sep 18, 2023 | BUY |
Buy
+109699900.0% avg upside
10 analysts
|
$3.00
2999899.99% Upside
|
· | · |
|
NCEL
NewcelX
|
Sep 14, 2023 | HOLD |
Buy
+438.5% avg upside
4 analysts
|
— | · | · |
|
ONCO
Onconetix
|
Sep 13, 2023 | HOLD |
Hold
1 analyst
|
— | · | · |
|
GOVX
GeoVax Labs
|
Aug 21, 2023 | BUY |
Strong Buy
+12088.7% avg upside
5 analysts
|
— | · | · |
|
PBLA
Panbela Therapeutics
|
Aug 21, 2023 | HOLD |
Buy
+49999999899.9% avg upside
3 analysts
|
— | · | · |
|
ABVC
ABVC BioPharma
|
Aug 21, 2023 | HOLD |
Hold
1 analyst
|
— | -63.4% | · |
|
MNPR
Monopar Therapeutics Inc
|
Aug 10, 2023 | HOLD |
Strong Buy
-15.2% avg upside
18 analysts
|
— | · | · |
|
GLMD
Galmed Pharmaceuticals
|
Jul 24, 2023 | BUY |
Buy
+412.8% avg upside
13 analysts
|
$4.00
12.24% Downside
|
· | · |
|
SCPX
Scorpius Holdings
|
Apr 03, 2023 | HOLD |
Strong Buy
+1831150.0% avg upside
11 analysts
|
— | · | · |
|
ARDS
Aridis Pharmaceuticals
|
Jan 26, 2023 | HOLD |
Strong Buy
+13249900.0% avg upside
5 analysts
|
— | · | · |
|
BTTC
Black Titan
|
Nov 22, 2022 | HOLD |
Hold
+1398.5% avg upside
2 analysts
|
— | · | · |
|
PTIX
Protagenic Therapeutics
|
Nov 22, 2022 | HOLD |
Hold
1 analyst
|
— | · | · |
|
BCDA
BioCardia
|
Nov 22, 2022 | HOLD |
Strong Buy
+1477.1% avg upside
5 analysts
|
— | · | · |
|
PRPO
Precipio
|
Nov 22, 2022 | HOLD |
Buy
-31.7% avg upside
2 analysts
|
— | -53.8% | · |
|
ERNA
Eterna Therapeutics
|
Nov 22, 2022 | HOLD |
Strong Buy
+1525.3% avg upside
4 analysts
|
— | · | · |
|
OMER
Omeros
|
Nov 15, 2022 | HOLD |
Buy
+14.0% avg upside
14 analysts
|
— | -43.9% | · |
|
ATAI
Atai Beckley N.V.
|
Nov 14, 2022 | BUY |
Buy
+23.4% avg upside
17 analysts
|
$12.00
63.90% Upside
|
-56.1% | · |
|
ENTX
Entera Bio
|
Nov 11, 2022 | BUY |
Strong Buy
+77.8% avg upside
3 analysts
|
$2.00
33.86% Downside
|
+40.0% | · |
|
INO
Inovio Pharmaceuticals
|
Nov 09, 2022 | HOLD |
Buy
+585.3% avg upside
19 analysts
|
— | · | · |
|
TSE:MDNA
Medicenna Therapeutics Corp
|
Nov 04, 2022 | BUY |
Strong Buy
+1064.1% avg upside
9 analysts
|
$5.56
1223.73% Upside
|
-60.8% | · |
|
SE:MVIR
Medivir AB
|
Aug 19, 2022 | BUY |
Strong Buy
+2171.7% avg upside
2 analysts
|
$28.60
1592.26% Upside
|
-8.2% | · |
|
ENVB
Enveric Biosciences
|
May 26, 2022 | BUY |
Strong Buy
+1090.2% avg upside
2 analysts
|
$25.00
1765.71% Upside
|
· | · |
|
HELP
Helus Pharma
|
Feb 11, 2022 | HOLD |
Strong Buy
+219.9% avg upside
13 analysts
|
— | -60.6% | · |
|
GILD
Gilead Sciences
|
Feb 03, 2022 | BUY |
Strong Buy
-19.1% avg upside
66 analysts
|
$84.00
43.09% Downside
|
+35.1% | · |
|
DMAC
Diamedica Therapeutics
|
Feb 02, 2022 | BUY |
Strong Buy
+119.4% avg upside
12 analysts
|
$6.00
10.74% Downside
|
-48.9% | · |
|
ADMA
ADMA Biologics
|
Jan 18, 2022 | HOLD |
Strong Buy
+9.3% avg upside
15 analysts
|
— | +145.3% | · |
|
TSE:APLI
Appili Therapeutics Inc Class A
|
Jan 18, 2022 | HOLD |
Hold
+12247.7% avg upside
3 analysts
|
— | -58.6% | · |
|
NAVBQ
Navidea
|
Jan 18, 2022 | HOLD |
Buy
+2833233.4% avg upside
4 analysts
|
— | · | · |
|
ONCSQ
OncoSec Medical
|
Oct 21, 2021 | HOLD |
Strong Buy
+4699999900.0% avg upside
9 analysts
|
— | · | · |
|
PLUR
Pluri
|
Oct 21, 2021 | HOLD |
Strong Buy
+263.4% avg upside
8 analysts
|
— | -75.9% | · |
|
ARMP
Armata Pharmaceuticals
|
Sep 08, 2021 | HOLD |
Strong Buy
+181.3% avg upside
4 analysts
|
— | -4.2% | · |
|
CTSO
Cytosorbents
|
Sep 08, 2021 | HOLD |
Strong Buy
+3237.9% avg upside
13 analysts
|
— | · | · |
|
BLRX
Bioline RX Ltd Sponsored ADR
|
Sep 08, 2021 | HOLD |
Buy
+232.8% avg upside
6 analysts
|
— | · | · |
|
PRFX
PainReform
|
Aug 27, 2021 | BUY |
Strong Buy
+500.0% avg upside
2 analysts
|
$6.00
499.95% Upside
|
· | · |
|
GRDX
GridAI Technologies
|
Aug 18, 2021 | BUY |
Strong Buy
+423.0% avg upside
7 analysts
|
$30.00
669.25% Upside
|
· | · |
|
LKFT
Lakefront Biotherapeutics
|
Aug 09, 2021 | HOLD |
Buy
+260.1% avg upside
24 analysts
|
— | -10.4% | · |
|
CLNN
Clene
|
Aug 05, 2021 | BUY |
Strong Buy
+685.4% avg upside
11 analysts
|
$18.00
333.31% Upside
|
· | · |
|
AVTX
Avalo Therapeutics
|
Aug 04, 2021 | BUY |
Strong Buy
+153.7% avg upside
20 analysts
|
$84.00
305.86% Upside
|
· | · |
|
VRTX
Vertex Pharmaceuticals
|
Jul 30, 2021 | HOLD |
Strong Buy
-18.7% avg upside
62 analysts
|
— | +39.1% | · |
|
VKTX
Viking Therapeutics
|
Jul 29, 2021 | BUY |
Strong Buy
+103.5% avg upside
31 analysts
|
$14.00
59.62% Downside
|
-50.3% | · |
|
ONC
BeOne Medicines
|
Jul 16, 2021 | HOLD |
Strong Buy
-3.7% avg upside
28 analysts
|
— | -45.7% | · |
|
TRAW
Traws Pharma
|
Jul 16, 2021 | HOLD |
Buy
+5729.1% avg upside
10 analysts
|
— | · | · |
|
NMTRQ
9 Meters Biopharma
|
Jun 17, 2021 | BUY |
Buy
+3234374900.0% avg upside
11 analysts
|
$3.00
299999899.92% Upside
|
· | · |
|
CRDF
Cardiff Oncology
|
May 07, 2021 | BUY |
Buy
+954.4% avg upside
18 analysts
|
$30.00
3266.96% Upside
|
-86.1% | · |
|
IDXG
Interpace Diagnostics Group
|
Apr 09, 2021 | HOLD |
Strong Buy
+661.8% avg upside
9 analysts
|
— | · | · |
|
XBIO
Xenetic Biosciences
|
Apr 09, 2021 | HOLD |
Hold
2 analysts
|
— | -50.7% | · |
|
SNGX
Soligenix
|
Apr 09, 2021 | HOLD |
Strong Buy
+764.9% avg upside
6 analysts
|
— | · | · |
|
NL:LKFT
Galapagos
|
Feb 10, 2021 | HOLD |
Sell
+105.8% avg upside
16 analysts
|
— | -17.5% | · |
|
INM
InMed Pharmaceuticals
|
May 11, 2020 | HOLD |
Hold
+1157.8% avg upside
3 analysts
|
— | · | · |
|
NVNO
enVVeno Medical
|
May 11, 2020 | HOLD |
Buy
+186.2% avg upside
2 analysts
|
— | · | · |
|
DXR
Daxor
|
Mar 26, 2020 | BUY |
Strong Buy
+109.1% avg upside
6 analysts
|
$22.00
109.83% Upside
|
-14.9% | · |
|
ABEO
Abeona Therapeutics
|
Nov 07, 2019 | HOLD |
Strong Buy
+177.7% avg upside
17 analysts
|
— | -62.1% | · |
|
GB:OXB
Oxford BioMedica
|
May 29, 2019 | HOLD |
Strong Buy
+69.5% avg upside
4 analysts
|
— | +3.8% | · |
|
GNPX
Genprex
|
May 29, 2019 | HOLD |
Strong Buy
+87.6% avg upside
5 analysts
|
— | · | · |
|
HEPA
Hepion Pharmaceuticals
|
May 29, 2019 | HOLD |
Strong Buy
+65614.3% avg upside
9 analysts
|
— | · | · |
|
ATHXQ
Athersys
|
May 09, 2019 | BUY |
Buy
+2996428471.5% avg upside
8 analysts
|
$8.00
799999900.04% Upside
|
· | · |
|
TEVA
Teva Pharmaceutical
|
May 02, 2019 | HOLD |
Buy
-19.1% avg upside
39 analysts
|
— | -31.9% | · |
|
BYSI
Beyondspring
|
Apr 30, 2019 | HOLD |
Hold
+976.1% avg upside
8 analysts
|
— | -4.3% | · |
|
TARA
Protara Therapeutics
|
Mar 28, 2019 | HOLD |
Strong Buy
+1204.0% avg upside
21 analysts
|
— | +9.3% | · |
|
VERU
Veru
|
Feb 13, 2019 | BUY |
Strong Buy
+651.1% avg upside
10 analysts
|
$6.00
130.39% Upside
|
+216.2% | · |
|
AVXL
Anavex Life Sciences
|
Jan 30, 2019 | HOLD |
Strong Buy
+613.6% avg upside
9 analysts
|
— | +55.4% | · |
|
CATX
Perspective Therapeutics
|
Jan 30, 2019 | HOLD |
Strong Buy
+219.8% avg upside
22 analysts
|
— | +100.0% | · |
|
SNOA
Sonoma Pharmaceuticals
|
Jan 30, 2019 | HOLD |
Buy
+1468.6% avg upside
4 analysts
|
— | · | · |
|
SINT
Sintx Technologies
|
Oct 03, 2018 | HOLD |
Strong Buy
+406.4% avg upside
8 analysts
|
— | · | · |
|
IPCIQ
IntelliPharmaCeutics International
|
Jun 15, 2018 | HOLD |
Buy
+1649999900.0% avg upside
4 analysts
|
— | · | · |
|
TSE:CSCI
COSCIENS Biopharma
|
Jun 15, 2018 | HOLD |
Strong Buy
+111.5% avg upside
8 analysts
|
— | · | · |
|
MNKD
MannKind
|
Jun 15, 2018 | HOLD |
Buy
+62.1% avg upside
22 analysts
|
— | -39.5% | · |
|
CANF
Can-Fite BioPharma
|
Jun 15, 2018 | HOLD |
Strong Buy
+47.6% avg upside
8 analysts
|
— | · | · |
|
TSE:BHC
Bausch Health Companies
|
Dec 14, 2017 | BUY |
Buy
+509.0% avg upside
29 analysts
|
— | +21.8% | · |
|
CASIF
CASI Pharmaceuticals
|
Nov 22, 2017 | HOLD |
Strong Buy
+18388.0% avg upside
5 analysts
|
— | · | · |
|
IMUC
ImmunoCellular Therapeutics
|
Nov 22, 2017 | HOLD |
Buy
+4066.6% avg upside
3 analysts
|
— | · | · |
|
AIXC
AIxCrypto Holdings
|
Sep 07, 2017 | HOLD |
Strong Buy
+646.5% avg upside
7 analysts
|
— | · | · |
|
BNTC
Benitec Biopharma
|
Aug 30, 2017 | HOLD |
Strong Buy
+87.4% avg upside
14 analysts
|
— | · | · |
|
SDEV
Stablecoin Development Corp
|
Aug 11, 2017 | HOLD |
Buy
+29.0% avg upside
7 analysts
|
— | · | · |
|
OTLC
Oncotelic Therapeutics
|
Aug 01, 2017 | HOLD |
Strong Buy
+8355.7% avg upside
5 analysts
|
— | -42.9% | · |
|
BPTH
Bio-Path Holdings
|
May 15, 2017 | BUY |
Strong Buy
+23877.9% avg upside
6 analysts
|
$20.00
57623.41% Upside
|
· | · |
|
EDSA
Edesa Biotech
|
May 10, 2017 | BUY |
Strong Buy
+94.2% avg upside
6 analysts
|
$2.00
65.26% Downside
|
· | · |
|
AGEN
Agenus
|
May 08, 2017 | BUY |
Strong Buy
+7.6% avg upside
18 analysts
|
$7.00
17.82% Downside
|
· | · |
|
BVNRY
Bavarian Nordic
|
May 05, 2017 | BUY |
Strong Buy
3 analysts
|
— | · | · |
|
SVRA
Savara
|
Apr 19, 2017 | HOLD |
Strong Buy
+56.4% avg upside
17 analysts
|
— | +4.2% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.